Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| LGVN | LONGEVERON INC | $21.61M | 15,009,306 | 2.98% | 97.02% | Net Selling | Net Selling | ||
| SABS | SAB BIOTHERAPEUTICS INC | $17.44M | 9,291,697 | 4.81% | 95.19% | ||||
| KYTX | KYVERNA THERAPEUTICS INC | $100.26M | 43,214,918 | 56.40% | 43.60% | Net Buying | |||
| IBIO | IBIO INC | $13.22M | 16,519,281 | 7.03% | 92.97% | Net Buying | |||
| PRTA | PROTHENA CORP PUBLIC LTD CO | $408.55M | 53,826,982 | 55.93% | 44.07% | Net Selling | Net Selling | ||
| RNXT | RENOVORX INC | $37.64M | 36,546,752 | 2.77% | 12.46% | Net Buying | Net Buying | ||
| CAPR | CAPRICOR THERAPEUTICS INC | $333.44M | 45,676,202 | 30.79% | 69.21% | Net Buying | Net Buying | ||
| NKTR | NEKTAR THERAPEUTICS | $132.13M | 186,103,588 | 71.41% | 14.11% | Net Selling | Net Selling | ||
| VIGL | VIGIL NEUROSCIENCE INC | $117.61M | 46,671,534 | 41.59% | 58.41% | Net Buying | |||
| GOSS | GOSSAMER BIO INC | $247.67M | 227,221,261 | 75.40% | 14.63% | Net Buying | |||
| TIL | INSTIL BIO INC | $83.14M | 6,525,887 | 6.44% | 93.56% | ||||
| LFWD | LIFEWARD LTD | $15.09M | 10,630,281 | 1.04% | 98.96% | Net Selling | |||
| CTSO | CYTOSORBENTS CORP | $54.38M | 62,500,000 | 24.53% | 44.74% | Net Buying | Net Buying | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $712.69M | 107,737,919 | 59.56% | 40.44% | Net Selling | Net Selling | ||
| RLAY | RELAY THERAPEUTICS INC | $485.19M | 171,444,966 | 77.28% | 22.72% | Net Selling | Net Selling | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $98.57M | 25,871,549 | 61.00% | 10.44% | Net Buying | |||
| EVAX | EVAXION BIOTECH A | $2.26M | 70,130,556 | 1.15% | 0.00% | ||||
| VERV | VERVE THERAPEUTICS INC | $369.39M | 88,795,768 | 63.38% | 36.62% | Net Buying | Net Selling | ||
| GEVO | GEVO INC | $297.12M | 239,609,874 | 21.53% | 11.98% | Net Selling | Net Selling | ||
| TARA | PROTARA THERAPEUTICS INC | $124.23M | 38,581,863 | 48.52% | 51.48% | Net Selling | Net Selling | ||
| SCPH | SCPHARMACEUTICALS INC | $116.66M | 50,283,925 | 64.26% | 35.74% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.